# OnCo record chengdu-new-radiomedicine-technology (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/chengdu-new-radiomedicine-technology/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "chengdu-new-radiomedicine-technology" ;
  schema:name "Chengdu New Radiomedicine Technology"@en ;
  schema:alternateName "Chengdu New Radiomedicine Technology Co., Ltd."@en, "NRT Medtech"@en, "成都纽瑞特医疗科技股份有限公司"@en ;
  schema:description "Chengdu New Radiomedicine Technology is a Chinese company that makes medical radioisotopes and radioactive cancer medicines. It is testing a FAP-targeted scan agent and treatment in advanced solid tumours, and a radioactive treatment given with chemotherapy in pancreatic cancer."@en ;
  schema:url <https://onco.cc/companies/chengdu-new-radiomedicine-technology/>, <http://www.nrtmedtech.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <http://www.nrtmedtech.com/>, <http://www.nrtmedtech.com/xinwendongtai/184.html>, <https://clinicaltrials.gov/study/NCT06278454>, <https://clinicaltrials.gov/study/NCT06911489> ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/>, <https://onco.cc/technologies/fapi-pet/> ;
  onco:targets <https://onco.cc/targets/fap/> .